Notably, cDCs have been correlated with RA disease activity, with reduced peripheral cDC numbers in highly active cases [16] and increased numbers in response to tumor necrosis factor (TNF) inhibitor therapy [14]. The gene discussed is TNF; the disease is rheumatoid arthritis.